Slate Path Capital as of Sept. 30, 2019
Portfolio Holdings for Slate Path Capital
Slate Path Capital holds 28 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Snap Inc cl a (SNAP) | 15.2 | $230M | 15M | 15.80 | |
| Charter Communications Inc New Cl A cl a (CHTR) | 12.8 | $193M | 469k | 412.12 | |
| Medicines Company | 12.2 | $185M | 3.7M | 50.00 | |
| Barrick Gold Corp (GOLD) | 11.2 | $170M | 9.8M | 17.33 | |
| New York Times Company (NYT) | 9.6 | $145M | 5.1M | 28.48 | |
| Kirby Corporation (KEX) | 7.4 | $112M | 1.4M | 82.16 | |
| General Electric Company | 6.1 | $93M | 10M | 8.94 | |
| Zillow Group Inc Cl C Cap Stk (Z) | 5.8 | $87M | 2.9M | 29.82 | |
| Mosaic (MOS) | 5.7 | $87M | 4.2M | 20.50 | |
| Pan American Silver Corp Can (PAAS) | 3.7 | $56M | 3.6M | 15.68 | |
| Alnylam Pharmaceuticals (ALNY) | 3.3 | $50M | 615k | 80.42 | |
| Intelsat Sa | 1.7 | $25M | 1.1M | 22.80 | |
| iShares MSCI Emerging Markets Indx (EEM) | 0.9 | $14M | 333k | 40.87 | |
| Sibanye Gold | 0.9 | $14M | 2.5M | 5.40 | |
| Cyclerion Therapeutics | 0.7 | $11M | 880k | 12.12 | |
| Reata Pharmaceuticals Inc Cl A | 0.6 | $9.6M | 120k | 80.29 | |
| Cue Biopharma (CUE) | 0.5 | $7.5M | 890k | 8.43 | |
| Zillow Group Inc Cl A (ZG) | 0.4 | $5.5M | 185k | 29.55 | |
| Invesco Qqq Trust Series 1 (QQQ) | 0.3 | $4.0M | 21k | 188.81 | |
| Blue Apron Hldgs Inc Cl A | 0.2 | $2.7M | 320k | 8.43 | |
| Lexinfintech Hldgs (LX) | 0.1 | $2.3M | 225k | 10.03 | |
| Pinduoduo (PDD) | 0.1 | $2.1M | 65k | 32.22 | |
| Freeport-McMoRan Copper & Gold (FCX) | 0.1 | $1.8M | 185k | 9.57 | |
| Tidewater (TDW) | 0.1 | $1.7M | 110k | 15.11 | |
| First Majestic Silver Corp (AG) | 0.1 | $1.5M | 170k | 9.09 | |
| Seadrill | 0.1 | $819k | 390k | 2.10 | |
| Mcdermott International Inc mcdermott intl | 0.0 | $586k | 290k | 2.02 | |
| United States Steel Corporation (X) | 0.0 | $462k | 40k | 11.55 |
